Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

2014: The year’s biggest Drug Development stories

GlaxoSmithKline (GSK) reported positive results from an Ebola vaccine Phase I trial, which showed that the drug was well-tolerated and produced an immunological response in each of the 20 healthy adults in the US.

Go Top